Expanding precision radioligand therapy through through modular platform collaboration.
The PreTarg-it® platform enables flexible development of precision radioligand therapies across multiple oncology targets in partnership with pharmaceutical and biotechnology companies.
Partnering Advantages
Modular Platform Integration
Flexible pairing of antibody targets and radiolabeled payloads.
Areas of Collaboration
OncoOne partners with pharmaceutical and biotechnology companies to expand the PreTarg-it® platform across new oncology targets.
We welcome collaborations that integrate partner-defined antibody assets or jointly develop novel radioligand therapy programs enabled by the modular platform.
PreTarg-it® is a modular pretargeted radioligand platform currently in preclinical development.
The architecture separates antibody-mediated tumor targeting from radionuclide delivery, enabling controlled systemic exposure and flexible target- payload pairing across oncology indications.
The architecture separates antibody-mediated tumor targeting from radionuclide delivery, enabling controlled systemic exposure and flexible target- payload pairing across oncology indications.
Structured for Precision. Built for Translation.
Strategic Engagement
We engage with pharmaceutical partners to define collaboration models aligned with scientific, clinical, and commercial objectives.
Asset-Level Co-Development
Integration of partner-defined antibody assets into the PreTarg-it® architecture to enable target-specific radioligand program development.
Regional or Global Licensing
Structured licensing frameworks supporting efficient clinical progression and geographic expansion.
Platform-Based Strategic Alliances
Broader collaboration models integrating the PreTarg-it® platform into defined oncology portfolios.
Target Expansion Programs
Joint development of novel radioligand programs leveraging the modular pretargeting framework.
PreTarg-it® Collaboration Architecture
Flexible collaboration models enable partners to integrate targets, advance programs, or expand the PreTarg-it® platform.
